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Upon sensing misfolded outer-membrane porins
(OMPs) in the periplasm, the E. coli DegS protease
cleaves RseA, a transmembrane regulator, transmit-
ting a signal to activate cytoplasmic gene expression.
Misfolding is detected by binding of normally inac-
cessible OMP sequences to the DegS-PDZ domain,
which relieves allosteric inhibition and activates
proteolysis. Here we show that DegS stimulation
can be regulated by OMP peptide affinity for the
active and for the inactive protease conformations,
as well as by preferential substrate binding to active
DegS. Based on the effects of mutations in the
peptide-binding pocket of the PDZ domain and else-
where, we suggest an allosteric pathway that links
peptide binding to DegS activation. These results
explain fast responses to envelope stress; demon-
strate that the protein-unfolding response, even
under catastrophic conditions, can be tailored by
the peptide sequences that become accessible to
DegS; and suggest strategies for control of related
PDZ proteases by allosteric effectors.
INTRODUCTION
PDZ proteases play important roles in protein quality control,
stress responses, and virulence in bacteria, and mutations in
human orthologs are frequently correlated with disease (Ehr-
mann and Clausen, 2004; Kim and Kim, 2005; Vande Walle
et al., 2008). In general, these enzymes function as trimers or
higher oligomers, and each subunit consists of a trypsin-like
protease domain and one or two PDZ domains. The protease
domain utilizes a conventional catalytic triad and oxyanion
hole, and the PDZ domains, which typically bind C-terminal
peptides, function in allosteric regulation of activity. Despite
the widespread biological importance of PDZ proteases, the
mechanisms that control the activities of these complex
enzymes are only beginning to be understood.
DegS is a trimeric PDZ protease that plays a crucial role in initi-
ation of the envelope-stress response in Escherichia coli and
related bacteria (Alba and Gross, 2004). It is anchored, via an
N-terminal segment, to the periplasmic side of the inner64 Molecular Cell 33, 64–74, January 16, 2009 ª2009 Elsevier Inc.membrane. When protein folding in the periplasm is compro-
mised, DegS cleaves the membrane-spanning protein RseA at
a single site. This event initiatesa cascadeof additional cleavages
by other proteases that destroy the cytoplasmic domain of RseA
and liberate the sE transcription factor, which enhances expres-
sion of genes that encode periplasmic chaperones, proteases,
and biosynthetic enzymes (Flynn et al., 2004; Rhodius et al.,
2006).Hence,a signal linked toproteinmisfolding in theperiplasm
is transduced across the inner membrane via a regulated proteo-
lytic cascade, leading to adaptive changes in gene expression.
How is cleavage of RseA controlled? Onemechanism involves
peptide binding to the DegS PDZ domains. By itself, purified
DegS cleaves RseA very slowly. However, peptides containing
a C-terminal YXF sequence motif, which is present in many
outer-membrane porins (OMPs), bind to the PDZ domains of
DegS and enhance the RseA-cleavage rate substantially (Walsh
et al., 2003; Sohn et al., 2007). OMPs are highly abundant enve-
lope proteins, and simple overexpression of OMPs or fusion
proteins containing their C-terminal sequences is sufficient to
induce the envelope-stress response (Mecsas et al., 1993;
Walsh et al., 2003). Moreover, the YxF motif is inaccessible in
native assembled OMPs (Basle´ et al., 2006). Thus, heat shock
and other types of environmental stress appear to lead to accu-
mulation of misfolded or unassembled OMPs, which then bind to
and activate DegS (Walsh et al., 2003; Alba and Gross, 2004).
Crystal structures of unliganded DegS and DegS bound to an
OMP peptide show two alternative conformations of the
protease domain (Wilken et al., 2004; Zeth, 2004). In peptide-
free DegS, the oxyanion hole of the active site is malformed,
suggesting that this conformation is enzymatically inactive. In
peptide-bound DegS, the structure of the oxyanion hole is that
of an active protease. However, bound OMP peptides are
more than 20 A˚ from the active sites in the DegS trimer
(Figure 1A), indicating that peptide must indirectly stabilize the
catalytically active conformation. Indeed, a plausible communi-
cation path between the peptide-binding site and active site
can be drawn (Figure 1B). In this pathway, OMP peptide binding
changes the conformation of Met319, which helps break a salt
bridge between Asp320 in the PDZ domain and Arg178 in the
protease domain, allowing the latter side chain to form a new
set of interactions that stabilize the functional oxyanion hole.
Previously, we presented evidence for an allosteric model in
which DegS equilibrates between inactive and active conforma-
tions, with OMP peptide binding driving the equilibrium to favor
the active state (Sohn et al., 2007). Evidence supporting this
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in DegS affinity for OMP peptides when salt bridges between the
PDZ domains and the protease domain that stabilize the inactive
conformation were eliminated by mutations. Moreover, deleting
the entire PDZ domain resulted in an enzyme with a high level of
peptide-independent RseA cleavage activity, and the crystal
structure of DegSDPDZ revealed a functional oxyanion hole.
Thus, interactions between the unliganded PDZ domain and
the protease domain must inhibit DegS activity, and OMP
peptide binding must counter this inhibition and stabilize active
DegS. A model in which OMP peptides bind only to active
DegS was consistent with the previously available experimental
data. Moreover, prior experiments suggested that the positive
cooperativity of substrate degradation arose from favorable
substrate-substrate interactions and not from preferential
binding of RseA to the active conformation of DegS.
New experiments presented here allow us to refine the DegS
allosteric model in several important ways. We find that OMP
peptides and RseA substrate bind both to inactive and active
DegS, with the degree of activation depending on the relative
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Figure 1. Conformational Activation of DegS
(A) Surface representation of inactive DegS (1TE0;
Zeth [2004]) with the protease domains colored
yellow and the PDZ domains gray. The active site
and OMP peptide-binding pocket are colored
blue and red, respectively.
(B) Changes in the conformations of selected DegS
residues between the inactive (cyan carbons;
1TE0) and active enzyme (brown carbons; 1SOZ;
Wilken et al., 2004) are indicated by arrows. OMP
peptide (VYQF) bound to active DegS is shown in
line representation (green). In inactive DegS, the
Met319 side chain appears to clash with bound
OMP peptide. The strain introduced by this clash
could help to break the Asp320dddArg178 and
Glu324dddLys243 salt bridges that stabilize inactive
DegS relative to active DegS. These disruptions,
in turn, could allow repositioning of the Arg178
side chain, which is known to play a critical role in
stabilizing the ‘‘active’’ conformation of the LD
loop and the active oxyanion-hole conformation
(Sohn et al., 2007).
affinities of these molecules for each
state. As a consequence, different OMP
peptides can maximally activate DegS to
dramatically different extents. Moreover,
we show that positive substrate coopera-
tivity arises from preferential substrate
binding to active versus inactive DegS
and that changes in RseA cleavage
caused by different OMP peptides or by
a variety of DegS mutations can be quan-
titatively modeled using the concerted
MWC formulation of allostery (Monod
et al., 1965). Finally, we suggest a pathway
of allosteric communication that allows
OMP peptide binding to stabilize active
DegS. Our model helps explain how the
biological response to envelope stress can occur so rapidly
and suggests molecular strategies for regulating DegS and
related PDZ proteases.
RESULTS
If a concerted allosteric model is appropriate, then DegS
protease activity should depend on the fraction of enzymes
that assume the active (relaxed) conformation rather than the
inactive (tense) conformation. This ratio will depend on the
intrinsic equilibrium between these states and on the concentra-
tions of activating peptide and substrate (Monod et al., 1965).
Another important factor is whether peptides bind exclusively
to the active enzyme or to both enzyme conformations. Below,
we test these possibilities.
Different OMP Peptides Activate DegS
to Very Different Extents
Although saturating concentrations of OMP peptides with
different central residues in the C-terminal YXF sequenceMolecular Cell 33, 64–74, January 16, 2009 ª2009 Elsevier Inc. 65
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Sohn et al., 2007), we found that sequence changes prior
to the YxF motif resulted in dramatically different maximal
rates of substrate cleavage by DegS. For example, maximal acti-
vation by two tripeptides (YYF, YQF) and four decapeptides
(DNRDGNVYYF, DNRDGNVYQF, EDGEDGDYYF, KRRKGKVYYF) differed
over a 35-fold range (Figure 2A; Table 1). These results rule out
a model in which peptides bind exclusively to relaxed DegS, as
mass action of saturating concentrations of any OMP peptide
would then drive all enzymes into the active conformation and
result in the same maximal activity.
Maximal activation did not correlate with the peptide concen-
tration required for 50% activation or with peptide length. The
YYF and YQF tripeptides activated DegS to similar maximal
extents but with activation curves displaced almost 10-fold in
concentration. In addition, the peptide with the highest apparent
affinity (KRRKGKVYYF) resulted in the lowest maximal activation.
Although the tripeptides activated DegS better than the decap-
eptides, large differences were also observed among the decap-
eptides. Moreover, peptides of 10 and 20 residues that activated
DegS as well as the best tripeptides were identified in other
studies (R. Chaba, B.M. Alba, B.C. Nmezi, J.S., R.T.S., and
C.A. Gross, unpublished data). These results show that peptide
sequences N-terminal to the YXF portion of OMP peptides can
strongly influence the extent of DegS activation.
Why is YYFdDegS a more efficient enzyme than DNRDGNVYYFd
DegS? When we determined steady-state kinetic parameters
for RseA cleavage in the presence of saturating YYF tripeptide,
KM was 370 ± 40 mM, and the turnover number (Vmax/DegStotal)
was 2.6 ± 0.2 s1 (Figure 3A). For saturating DNRDGNVYYF peptide,
by contrast, KM was about 2-fold higher, and the turnover
number was about 2-fold lower (Table 1; Sohn et al., 2007).
Thus, any model for peptide activation needs to explain how
the chemical identity of the bound OMP peptide can change
KM and the turnover number.
Testing a Model for Varied Peptide Activation
To rationalize these results in terms of an allosteric model, OMP
peptides would need to bind to both relaxed and tense DegS.
The degree of maximal activation would then depend on how
tightly a given peptide bound to each conformation. One predic-
tion if peptides bind both DegS states is that maximal peptide
activation should depend on the intrinsic equilibrium distribution
of the tense and relaxed enzyme states. Specifically, a peptide
that activated wild-type DegS relatively poorly should result in
better activation of a DegS mutant in which the free-energy
difference between the active and inactive conformations was
decreased.
The K243D and D320A mutations disrupt salt bridges that
stabilize the interface between the PDZ domain and protease
domain in inactive but not active DegS (Figure 1B; Wilken
et al., 2004; Zeth, 2004). DegS variants with either mutation
behave as if more unliganded enzymes adopt the active confor-
mation, displaying increased activity in the absence of peptide
and requiring less peptide for stimulation (Sohn et al., 2007).
Here we found that the K243D and D320A mutants cleaved
a single sub-KM concentration of RseA about 3-fold faster than
did wild-type DegS in the presence of saturating DNRDGNVYQF66 Molecular Cell 33, 64–74, January 16, 2009 ª2009 Elsevier Inc.0
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Figure 2. OMP Peptide Activation of DegS and Mutants
(A) Peptide activation of RseA cleavage by wild-type DegS (%0.5 mM trimer).
The DNRDGNVYYF data are from Sohn et al. (2007).
(B) Activation of wild-type DegS and the D320A and K243D mutants (0.1 mM
trimer) by DNRDGNVYQF.
(C) YYF activation of the M319A DegS mutant. In all panels, the concentration
of the RseA periplasmic domain was 200 mM, and the lines are fits to the
following equation: velocity = basal + max/(1+[Kact/(peptide)]
n), where n is
the Hill constant.
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OMP Peptide Control of DegS Activitypeptide (Figure 2B; Table 1). Moreover, in Michaelis-Menten
experiments performed with saturating DNRDGNVYYF, both
mutants had higher Vmax values than wild-type DegS (Figures
3A and 3B; Table 1). Thus, both DNRDGNVYQF and DNRDGNVYYF,
which activate wild-type DegS only moderately compared to
some peptides (Table 1), convert more of the K243D and
D320A enzymes into the active state. Conversely, the YYF
peptide, which was one of the best activators of wild-type
DegS, activated these mutants only marginally better than
wild-type DegS at a single substrate concentration (Table 1)
and resulted in Vmax values that were roughly within error for
wild-type and the mutants (Table 1). This result is expected if
the degree of activation depends both on the binding preference
of a given peptide for the two states of DegS and on the intrinsic
equilibrium between these states. In other words, peptides that
bind sufficiently tightly to active DegS compared to inactive
DegS (e.g., YYF) can convert most enzymes into the active
conformation, even when the conformational equilibrium is less
favorable.
Compared to wild-type DegS, half-maximal activation (Kact) of
the K2,43D and D320A mutant enzymes was observed at lower
concentrations of a given OMPpeptide and the activation curves
had smaller Hill constants, indicating reduced positive coopera-
tivity of activation (Figure 2B; Table 1). Tighter peptide binding
and reduced positive cooperativity are expected if less of the
peptide-binding energy is needed to drive the tense-to-relaxed
conversion for the mutants compared to wild-type DegS. The
KMs and Hill constants for the RseA substrate were also lower
for the K243D and D320A enzymes than for wild-type DegS
(Table 1). Indeed, with saturating DNRDGNVYYF, the substrate Hill
constants for the D320A (1.1 ± 0.2) and K243D/D320A (1.1 ±
0.1) enzymes were within error of 1, whereas the value for wild-
typeDegSwas 1.6 ± 0.2 (Table 1). These results strongly suggest
that the RseA substrate also binds preferentially to active versus
inactive DegS and thus helps to stabilize the catalytically compe-
tent enzyme (see the Discussion). By this model, positive coop-
erativity in substrate binding would only be expected under
conditions in which peptide binding alone was not sufficient to
drive most DegS molecules into the active conformation.
A DegS Mutation that Reduces Maximal Activation
Amodel in which OMP peptides bind both to the tense and to the
relaxed enzyme conformations also predicts that some DegS
mutations should diminish activation by reducing peptide-
binding preference for the active enzyme. We screened several
DegS mutations that alter side chains that contact bound OMP
peptide and found one mutant (M319A) that displayed markedly
lower levels of peptide activation (Figure 2C; Table 1). For
example, saturating YYF resulted in M319A activity that was
20-fold lower than the wild-type DegS value, and peptides that
partially activated wild-type DegS resulted in even lower levels
of M319A activation (Table 1).
Because OMP peptides still activate M319A, they must bind
somewhat more tightly to the relaxed than to the tense state of
the mutant enzyme. Poor activation of M319A could be ex-
plained if peptide binding to the relaxed state of this mutant is
only modestly better than to the tense state or if the mutation
stabilizes the tense relative to the relaxed enzyme. Multipleresults support the former explanation. First, the basal activity
of the M319A mutant was slightly higher (4.5 ± 1.0 M1s1)
than that of wild-type DegS (2.9 ± 0.5 M1s1). This result is
inconsistent with tense-state stabilization, which predicts lower
basal activity. Second, when we constructed and characterized
the K243D/M319A double mutant, its basal activity (490 ±
50 M1s1) was about twice that of the K243D enzyme (210 ±
30 M1s1), indicating that the M319Amutation actually contrib-
utes to relaxed-state stabilization. Third, saturating concentra-
tions of the YYF peptide activated the K243D/M319A double
mutant to levels (2700 ± 400 M1s1) only modestly lower than
those of the K243D enzyme (3400 ± 550 M1s1). This result
shows that enzymes bearing the M319A mutation are capable
of robust cleavage of RseA. Fourth, saturating concentrations
of the DNRDGNVYYF peptide, which is a poorer activator than YYF,
enhanced K243D/M319A activity to a level (1100 ± 130 M1s1)
lower than that of the K243D enzyme (1700 ± 150 M1s1).
Hence, the M319A mutation, alone or in combination with other
mutations, reduces the ability of multiple peptides to activate
DegS. Taken together, these results indicate that the M319A
mutation has two effects, stabilizing the active relative to the
inactive enzyme and decreasing the binding preference of
OMP peptides for active DegS. By itself, the first effect would
enhance peptide activation. Because depressed activation
was observed, however, the second effect must dominate.
The side chain of Met319 in wild-type DegS contacts the
C-terminal phenylalanine of bound OMP peptide (Figure 1B;
Wilken et al., 2004), and thus M319A DegS might be expected
to bind OMP peptides more weakly. Exactly the opposite result
was observed. This mutant was half-maximally activated by
the YYF tripeptide at a 10-fold lower concentration than wild-
type DegS (Table 1). Moreover, in direct binding assays, both
the M319A and K243D/M319A mutants bound roughly 35-fold
more tightly than wild-type DegS to a fluorescent OMP peptide
(Figure 3C). These increases in peptide-binding affinity are
substantially greater than can be explained by modest stabiliza-
tion of the relaxed enzyme by the M319A mutation. Indeed,
modeling suggests that tense M319A DegS binds YYF peptide
about 20-fold more tightly than does tense wild-type DegS
(see below). In the Discussion, we propose a role for unfavorable
contacts between OMP peptides and the Met319 side chain in
tense DegS in biasing the allosteric equilibrium toward the active
conformation.
Peptide Activation of Active-Site Reactivity
As an independent test of the influence of peptide binding on the
two competing DegS conformations, we used a fluorescent
derivative of fluorophosphate called rhodamine-FP (Liu et al.,
1999) and monitored enzyme modification of the active-site
serine by fluorography after SDS-PAGE (Figure 4A). Wild-type
DegS did not detectably react with rhodamine-FP unless acti-
vating peptide was present, a result consistent with previous
studies using diisopropylfluorophosphate (Sohn et al., 2007).
Modification was fastest in the presence of saturating YYF
peptide, slower with the DNRDGNVYYF peptide, slower still with
the EDGEDGDYYF peptide, and slowest with the KRRKGKVYYF
peptide (Figure 4B). This order of reactivity was the same as
that observed for peptide activation of DegS cleavage of RseA.Molecular Cell 33, 64–74, January 16, 2009 ª2009 Elsevier Inc. 67
Molecular Cell
OMP Peptide Control of DegS ActivityTable 1. Parameters for DegS Cleavage and/or OMP Peptide Binding Activity
Enzyme OMP Peptide
Activation Parameters
Maximum Activity (M1s1) Kact (mM) Hill Constant
Wild-type none 2.9 ± 0.5 n.a. n.a.
Wild-type DNRDGNVYYF 730 ± 80 3.9 ± 0.8 1.8 ± 0.2
Wild-type DNRDGNVYQF 590 ± 70 50 ± 5 1.6 ± 0.1
Wild-type EDGEDGDYYF 290 ± 60 73 ± 10 1.3 ± 0.1
Wild-type KRRKGKVYYF 70 ± 7 %1 mMa 1.2a
Wild-type YYF 2500 ± 550 29 ± 3 1.7 ± 0.1
Wild-type YQF 2100 ± 200 260 ± 10 1.6 ± 0.1
K243D None 210 ± 30 n.a. n.a.
K243D DNRDGNVYYF 1700 ± 150 0.3 ± 0.1 b
K243D DNRDGNVYQF 1800 ± 200 5.3 ± 1.2 1.3 ± 0.1
K243D YYF 3400 ± 550 6.4 ± 1.6 1.4 ± 0.2
D320A None 100 ± 20 n.a. n.a.
D320A DNRDGNVYYF 2100 ± 200 0.2 ± 0.1 b
D320A DNRDGNVYQF 2300 ± 200 6.3 ± 1.3 1.2 ± 0.1
D320A EDGEDGDYYF 1020 ± 150 14 ± 2 1.3 ± 0.1
D320A KRRKGKVYYF 810 ± 80c n.d. n.d.
D320A YYF 3600 ± 450 4.8 ± 1.2 1.4 ± 0.1
M319A None 4.5 ± 1.0 n.a. n.a.
M319A DNRDGNVYYF 20 ± 2c n.d. n.d.
M319A DNRDGNVYQF 18 ± 2c n.d. n.d.
M319A KRRKGKVYYF 6 ± 1c n.d. n.d.
M319A YYF 120 ± 20 3.2 ± 0.4 1.1 ± 0.1
K243D/M319A None 490 ± 50 n.a. n.a.
K243D/M319A DNRDGNVYYF 1100 ± 130c n.d n.d
K243D/M319A YYF 2700 ± 400 0.7 ± 0.2 1.2 ± 0.1
Michaelis-Menten Parameters
Enzyme OMP Peptide Vmax (s
1enz1) KM (mM) Hill Constant
Wild-type DNRDGNVYYF 1.1 ± 0.2 750 ± 120 1.6 ± 0.2
Wild-type YYF 2.6 ± 0.2 370 ± 40 1.4 ± 0.2
K243D DNRDGNVYYF 1.8 ± 0.2 580 ± 30 1.3 ± 0.1
K243D YYF 2.3 ± 0.1 440 ± 30 1.3 ± 0.1
D320A DNRDGNVYYF 2.5 ± 0.3 520 ± 90 1.1 ± 0.2
D320A YYF 3.1 ± 0.3 430 ± 50 1.2 ± 0.1
K243D/D320A DNRDGNVYYF 2.0 ± 0.3 630 ± 100 1.1 ± 0.1
K243D/M319A DNRDGNVYYF 1.4 ± 0.1 840 ± 90 1.2 ± 0.1
K243D/M319A YYF 2.1 ± 0.2 490 ± 40 1.2 ± 0.1
OMP Peptide Binding
Enzyme KD (mM)
Wild-type 4.6 ± 0.3
M319A 0.14 ± 0.03
K243D/M319A 0.18 ± 0.02
Fitted MWC Allosteric Parameters
Enzyme OMP Peptide kr (s
1) L0 KRS (mM) KTS (mM) KRP (mM) KTP (mM) KTP/KRP L3 Peptide
Wild-type DNRDGNVYYF 3.3 15000 150 505 0.20 1.36 6.8 50
Wild-type KRRKGKVYYF 3.3 15000 150 505 0.23 0.76 3.3 420
Wild-type DNRDGNVYQF 3.3 15000 150 505 2.1 12.8 6.1 61
Wild-type YYF 3.3 15000 150 505 1.51 18.6 12.3 8
K243D DNRDGNVYYF 3.3 180 150 505 0.07 0.14 2.0 2168 Molecular Cell 33, 64–74, January 16, 2009 ª2009 Elsevier Inc.
Molecular Cell
OMP Peptide Control of DegS ActivityTable 1. Continued
Fitted MWC Allosteric Parameters
Enzyme OMP Peptide kr (s
1) L0 KRS (mM) KTS (mM) KRP (mM) KTP (mM) KTP/KRP L3 Peptide
K243D DNRDGNVYQF 3.3 180 150 505 1.64 3.19 1.9 25
K243D YYF 3.3 180 150 505 1.24 3.76 3.0 6.5
D320A DNRDGNVYYF 3.3 350 150 505 0.06 0.2 3.3 11
D320A EDGEDGDYYF 3.3 350 150 505 4.02 8.5 2.1 37
D320A DNRDGNVYQF 3.3 350 150 505 1.09 2.98 2.8 16.4
D320A YYF 3.3 350 150 505 0.9 3.7 4.1 5
M319A YYF 3.3 5500 150 505 0.34 0.91 2.7 290
K243D/M319A YYF 3.3 90 150 505 0.33 0.68 2.1 10.3
a The fitted Kact was too close to the enzyme concentration (0.5 mM monomer) to determine reliable ‘‘free’’ peptide, and thus a Hill constant.
bBinding was too tight to determine a reliable Hill constant.
cComplete titration curves were not determined, but near saturation was confirmed by testing at least two peptide concentrations that differed by
a 2-fold minimum.
Activation parameters were determined by experiments like those shown in Figures 2A and 2B. Values in italics are from Sohn et al. (2007); n.d., not
determined; n.a., not applicable. In ‘‘OMP Peptide Binding,’’ the binding affinities are for the peptide fluoresceine-b-alanine-KKDNRDG
NYYF. Experimental values are an average of two ormore independent determinations. Errors were calculated as
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1=ðn 1ÞPn
1
ðvaluemeanÞ2
s
where
n is the number of independent trials. In ‘‘Fitted MWC Allosteric Parameters,’’ L3 is the equilibrium constant
relating the peptide-saturated tense and relaxed states (see Figure 5).Hence, both assays show that the binding of different OMP
peptides can result in substantially different degrees of partition-
ing between the active and inactive conformations of wild-type
DegS.
In the absence of OMP peptide, the D320A mutant was modi-
fied, albeit slowly, by rhodamine-FP (Figure 4C), whereas
wild-type DegS was not modified. This result is expected if the
D320A mutation increases the equilibrium population of the
active enzyme.Moreover, different activating peptides enhanced
rhodamine-FP modification of the D320A mutant in roughly the
same order as that observed for wild-type DegS, but to higher
levels of modification (Figure 4C). For the best activating
peptides, these differences in D320A activation were close to
the error of the measurement. Because less peptide-binding
energy is needed to convert D320A DegS into the active confor-
mation, it is possible that all of these peptides activate D320A to
roughly comparable extents.
In the presence of saturating OMP peptides, the M319A
mutant showedmuch lower levels of rhodamine-FPmodification
than wild-type DegS or the D320A mutant, but the K243D/
M319A double mutant showed substantial modification
(Figure 4C). These results indicate that OMP peptides bind
with a reduced preference to the relaxed state of the M319A
variant, an effect that can be overcome by stabilization of the
active enzyme form by an additional mutation. Overall, the
results of rhodamine-FP modification support the idea that
DegS activation depends both on the preference of individual
peptides for binding to the relaxed and tense states and on the
intrinsic equilibrium between these states.
Modeling
The results described above support an allostericmodel in which
DegS exists as an equilibrium mixture of active and inactive
enzymes and OMP peptides alter RseA cleavage by binding
with different affinities to these two enzyme conformations. Todetermine if the effects of peptide binding, substrate binding,
and DegS mutations could be modeled, we performed global
fitting to equations derived from the MWC model of allostery
(Monod et al., 1965). Because DegS is a trimer, the MWC model
predicts 16 relaxed and 16 tense equilibrium species, which
differ in the number of bound OMP peptides and/or in the
number of bound RseA substrates. The relative populations of
these species at any given concentration of peptide and
substrate can be calculated from the equilibrium constant (L0)
for conversion of the unliganded relaxed (R) state to the tense
(T) state, the microscopic equilibrium dissociation constants of
OMP peptides for a T state subunit (KTP) or an R state subunit
(KRP), and the microscopic equilibrium dissociation constants
of substrate for a T state subunit (KTS) or an R state subunit
(KRS). For example, Figure 5 shows the equilibrium relationships
between T state and R state trimers without ligands, with three
peptides bound, with three substrates bound, and with three
peptides and three substrates bound. Because a functional oxy-
anion hole is absent in peptide-free structures of DegS (Wilken
et al., 2004; Zeth, 2004), we assumed that T state species are
enzymatically inactive. Thus, DegS cleavage activity is a function
of the concentration of substrate-bound R state subunits and the
rate constant (kr) for cleavage of RseA by these subunits.
Good fits of the experimental data were obtained using the
same values of KTS, KRS, and kr for wild-type DegS and all
mutants; individual values of L0 for wild-type DegS, and the
K243D, D320A, M319A, and K243D/M319A mutants; and KTP
and KRP values specific for each peptide and enzyme (Table 1).
Using these parameters resulted in excellent correlations (R >
0.98) between the predicted and experimental parameters that
characterize the OMP peptide dependence of RseA cleavage
by DegS and its variants, including maximal activation and the
concentration dependence of activation (Figures 6A and 6B).
The correlations between the predicted and experimental values
of KM (R = 0.87) and Vmax (R = 0.95) for RseA cleavage byMolecular Cell 33, 64–74, January 16, 2009 ª2009 Elsevier Inc. 69
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were also good (Figures 6C and 6D) given the relatively small
range of these values. We conclude that the MWC model
provides a good description of the allosteric regulation of DegS
A
B
C
Figure 3. Substrate Binding and Control of Activity
(A) Substrate dependence of the steady-state rate of cleavage by wild-type
DegS (0.5 mM trimer) with YYF peptide (300 mM). For comparison, rates in
the presence of saturating DNRDGNVYYF peptide (Sohn et al., 2007) are also
shown.
(B) Substrate dependence of the cleavage by the K243D, D320A, and K243D/
D320A mutants of DegS (0.3 mM trimer) with DNRDGNVYYF peptide (30 mM).
(C) Binding of DegS, the M319A mutant, and the K243D/M319A mutant to the
OMP peptide fluoresceine-b-alanine-KKDNRDGNYYF (20 nM) weremonitored
by changes in fluorescence anisotropy. The lines are fits to a quadratic form of
a hyperbolic binding isotherm. The data for wild-type DegS are fromSohn et al.
(2007). In (A) and (B), the lines are fits to the Hill form of the Michaelis-Menten
equation: velocity = Vmax/(1+(KM/[substrate])
n).70 Molecular Cell 33, 64–74, January 16, 2009 ª2009 Elsevier Inc.and mutant variants by the binding of OMP peptides and RseA
substrate.
When both peptide and substrate are saturating, our model
predicts that the fractional activity of DegS equals 1/(1+L0/
[(KTP/KRP)
3
d(KTS/KRS)
3]). However, the KTS/KRS value (3.4)
was constant for DegS and its mutants, indicating that RseA
binds about 3-fold more tightly to relaxed than to tense DegS.
The fractional activity expression then simplifies to 1/(1+L0/
[(3.4dKTP/KRP)
3]). Consequently, changes in the initial equilibrium
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Figure 4. Peptide Dependence of Active-Site Modification
(A) SDS-PAGE of wild-type DegS after reaction with rhodamine-FP in the pres-
ence of two OMP peptides. Fluorescence is shown in the upper strips and
Coomassie blue staining in the lower strips.
(B) Rhodamine-FP (20 mM)modification of wild-type DegS (0.9 mM trimer) in the
presence of saturating concentrations of four OMP-like peptides. The lines are
linear fits (RR 0.975).
(C) Rates of rhodamine-FP modification of wild-type DegS and the D320A,
M319A, and K243D/M319A mutants without peptide or with saturating OMP
peptides. Rates were normalized to an arbitrary value of 100 for wild-type
DegS with saturating DNRDGNVYYF peptide. The error bars represent standard
deviations based on three or more experiments.
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OMP Peptide Control of DegS Activityconstant (L0) and the ratio of the peptide-binding constants for
tense and relaxed DegS ([KTP/KRP]
3) determine how different
OMP peptides, under saturating conditions, and mutations
affect DegS activity. For wild-type DegS, the fitted L0 value
was 15,000, and the fitted KTP/KRP values for the YYF,
DNRDGNVYYF, and KRRKGKVYYF peptides were 12.3, 6.8, and 3.3,
respectively. Although these differences in binding preference
seemmodest, they are magnified in the peptide-saturated trimer
because the equilibrium constant relating the tense and relaxed
enzyme conformations (L3) is equal to L0/([KTP/KRP]
3). Thus, in
the presence of saturating substrate, saturating YYF drives
83% of DegS molecules into the active conformation, whereas
DNRDGNVYYF and KRRKGKVYYF result in 45% and 9% active
enzyme, respectively.
The MWC fitting results indicate that the K243D, M319A, and
D320Amutations reduce L0 and also decrease KTP/KRP (Table 1).
Because these mutations affect residues near the PDZ domain/
protease domain interface and the peptide-binding site
(Figure 1), it is not surprising that each mutation affects the allo-
steric equilibrium and the peptide-binding preference. However,
a reduction in L0 enhances DegS activity, whereas a reduction in
KTP/KRP decreases peptide stimulation of activity. Thus, the
phenotype caused by a given mutation depends on the degree
to which each parameter is changed. Compared to wild-type
DegS, L0 for the M319A mutant is reduced about 3-fold, but
(KTP/KRP)
3 for YYF is reduced almost 100-fold. The large
decrease in the latter term outweighs the modest decrease in
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Figure 5. Allosteric Relationships
Equilibria between relaxed DegS trimers (circles) and tense DegS trimers
(squares) are perturbed by the binding of OMP peptides and RseA substrate.
For simplicity, partially liganded states are not shown. Species that comprise
the top face of the cube have three OMP peptides bound; species that
comprise the back face of the cube have three RseA substrates bound. The
front face of the cube consists of substrate-free trimers. The bottom face of
the cube consists of peptide-free trimers. Horizontal arrows indicate confor-
mational equilibria. Vertical arrows signify reactions in which three OMP-like
peptides associate or dissociate from DegS. Arrows at an angle indicate reac-
tions in which three molecules of the RseA substrate associate or dissociate
from DegS. Cleavage of RseA only occurs from substrate-bound relaxed
DegS.L0, and thus saturating YYF peptide and substrate drive only
about 10% of themutant M319A enzymes into the active confor-
mation. For the K243D and D320A mutants, however, L0 is
reduced 40- to 80-fold and (KTP/KRP)3 for YYF binding is
reduced 30- to 70-fold. In these cases, the large decrease in
L0 overwhelms the suppressing effects of the decreased
peptide-binding preference, and thus saturating RseA and YYF
peptide drive about 85% of the mutant K243D and D320A
enzymes into the active conformation. Overall, these results
show that the MWC allosteric model provides an explanation
for the effects of mutations, peptide-binding preference, and
peptide and substrate concentration in determining the proteo-
lytic activity of DegS.
DISCUSSION
Activation by OMP Peptides
Our results demonstrate that saturating concentrations of
different OMP peptides activate DegS to dramatically different
degrees. For example, the rate at which DegS cleaved the peri-
plasmic domain of RseA varied by as much as 35-fold, depend-
ing upon the activating peptide. Activation was also a function of
the equilibrium between the active and inactive conformations of
DegS. For a given peptide, higher levels of activation were
observed for DegS mutants in which the conformational equilib-
rium was shifted toward the relaxed state. These results indicate
that peptides bind to the active and inactive conformations of
DegS, with the degree of activation depending upon the relative
affinity of a given peptide for each conformation. This model has
an interesting biological implication, namely, that different acti-
vating OMP sequences could evolve to elicit graded responses
in terms of DegS activation and subsequent induction of the
envelope-stress response. Thus, it will be important to establish
how different natural OMP sequences interact with DegS and the
extent to which specific OMPs function in stress signaling. For
example, differential sensitivity of individual OMPs to heat stress,
acid shock, or oxidative stress might result in differential induc-
tion of the sE-stress response even under catastrophic condi-
tions in which the activating signals are saturating.
The C-terminal YXF motif of OMPs was initially identified as
a sequence that bound to the PDZdomain of DegS and activated
cleavage of RseA (Walsh et al., 2003). In the studies reported
here, OMP peptides with identical C-terminal tripeptides re-
sulted in highly varied levels of maximal activation. Thus,
upstream residues before the YXF sequence can play important
roles in activation. Presently, there are three structures of DegS
or an ortholog bound to activating peptides, but none show
contacts between the enzyme and peptide residues upstream
of the four C-terminal residues (Wilken et al., 2004; Hasselblatt
et al., 2007; Mohamedmohaideen et al., 2008). These upstream
residues may interact with DegS electrostatically. Indeed, we
observed markedly worse activation when the upstream resi-
dueswere highly basic as opposed to highly acidic. Alternatively,
upstream residues might influence activation largely through
contacts with inactive DegS, as all known peptide-bound struc-
tures represent the active enzyme conformation. Small differ-
ences in peptide binding can have significant functional effects.
For example, our best activating peptides bind to a relaxedMolecular Cell 33, 64–74, January 16, 2009 ª2009 Elsevier Inc. 71
Molecular Cell
OMP Peptide Control of DegS Activitysubunit of wild-type DegS about 12-fold better than to a tense
subunit, and this preference is reduced to about 3-fold for the
worst activating peptide. Differences of this magnitude corre-
spond to a free-energy change of 0.7–1.5 kcal/mole per subunit
and thus could depend on a small number of favorable or unfa-
vorable contacts between the peptide and either conformational
state of DegS. Because these small energy differences are
magnified in the peptide-saturated DegS trimer, however, indi-
vidual OMP peptides can differ greatly in activation potential.
Other models for DegS activation by OMP peptide have been
suggested. For example, it was proposed that the identity of the
penultimate residue of the OMP peptide and the nature of its
interactions with the L3 loop of DegS were critical determinants
of activation (Wilken et al., 2004; Hasselblatt et al., 2007). Here
and previously (Sohn et al., 2007), however, we found that satu-
rating concentrations of OMPpeptideswith different penultimate
residues activate DegS similarly. Indeed, maximal activation by
peptides differing only at the penultimate residue varies from
the average by less than 20%. It is likely that these small effects
reflect minor differences in peptide affinity for active and inactive
DegS, but we find no evidence to support a model in which
specific contacts between the penultimate peptide side chain
and DegS play crucial roles in activation. In this regard, we note
that the penultimate side chain of the activating peptide in the
structure of a DegS ortholog from M. tuberculosis makes no
contacts with the protease domain (Mohamedmohaideen et al.,
2008).
Activation of the envelope-stress response occurs in minutes
in vivo, and OMP peptide activation of DegS in vitro occurs even
more rapidly (Ades et al., 1999; Sohn et al., 2007). OMP peptide
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Figure 6. Correlations between Predicted
and Experimental Parameters
(A) Second-order rate constants for cleavage by
DegS or mutants with saturating OMP peptide
and RseA substrate (200 mM).
(B) OMP peptide concentrations required for half-
maximal activation of RseA (200 mM) cleavage by
DegS or mutants.
(C) Maximal rates of cleavage by DegS or mutants
with saturated RseA substrate and OMP peptide.
(D) Substrate concentration required for half-
maximal cleavage by DegS or mutants with satu-
rating OMP peptide. In each panel, predicted
values were calculated from the MWC allosteric
model using the parameters listed in Table 1,
and the correlation coefficients are for fits to the
equation y = x.
binding to both inactive and active DegS
helps explain fast activation. Specifically,
most OMP peptides would be expected
to bind initially to inactive DegS mole-
cules, with intramolecular conversion to
the active enzyme occurring after binding
of multiple peptides. By contrast, if OMP
peptides bound exclusively to active
DegS, then only a small fraction of total
unliganded enzymes would serve as
peptide receptors, and activation could easily be limited by
slow initial binding. For example, if we assume that the rate
constant for binding of OMP peptides to both conformation of
DegS is the same, then binding to inactive DegS would occur
at an initial rate about 15,000-fold faster than to active DegS
because of the difference in the equilibrium populations of
both species.
Substrate-Binding Cooperativity Revisited
Previously, we found that a DegS mutant lacking the PDZ
domain (DegSDPDZ) had essentially the same RseA-cleavage
activity as wild-type DegS bound to DNRDGNVYXF peptides
(Sohn et al., 2007). We interpreted this result as evidence that
all DegSDPDZ molecules assumed an active conformation, which
suggested that the positive cooperativity observed in substrate
cleavage by DegSDPDZ and DegS arose from favorable sub-
strate-substrate interactions rather than from preferential
substrate binding to the relaxed enzyme. However, the results
presented here show that wild-type DegS is not fully activated
by DNRDGNVYXF peptides and thus cast doubt on the substrate-
interaction model. One prediction of the substrate-substrate
interaction model is retention of substantial positive cooperativ-
ity when almost all DegS enzymes are in the relaxed conforma-
tion. Our present results are inconsistent with this model. Specif-
ically, whenwe stabilized R state DegS by destabilizing the tense
state with the K243D/D320A mutations, the Hill constant for
substrate cleavage in the presence of saturating OMP peptide
was 1.1 ± 0.1. Because a Hill constant of 1 indicates no cooper-
ativity, we conclude that most positive cooperativity in substrate
binding for the wild-type enzyme results from preferential72 Molecular Cell 33, 64–74, January 16, 2009 ª2009 Elsevier Inc.
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OMP Peptide Control of DegS Activitybinding of RseA to relaxed DegS. Indeed, fitting of our experi-
mental data to the MWCmodel suggests that an RseA substrate
binds 3.4-fold more tightly to an R state DegS subunit than
a T state subunit. This difference would be magnified to approx-
imately 40-fold in the substrate-saturated DegS trimer.
Allosteric Control
In the absence of substrate and OMP peptides, our results indi-
cate that the ratio of inactive:active DegS is about 15,000:1. In
the presence of saturating RseA substrate, this ratio changes
to about 400:1, allowing a low rate of basal RseA cleavage.
Our best OMP peptides shift the conformational equilibrium
more dramatically. For example, saturating YYF tripeptide shifts
the inactive:active ratio to 8:1 in the absence of substrate and to
1:5 with saturating RseA.
Some DegS cleavage of RseA is required for cell viability (Alba
et al., 2001). Peptide-independent basal cleavage might satisfy
this demand, or low levels of unassembled OMPs present under
normal growth conditions might stimulate somewhat higher
levels of cleavage. DegS and RseA are both bound to the inner
membrane in E. coli. Hence, colocalization probably stabilizes
substrate-enzyme binding, compared to the relatively weak
binding observed in soluble assays in vitro. Importantly,
however, our modeling indicates that higher effective concentra-
tions of the substrate would not change the allosteric equilibrium
significantly because both relaxed and tense DegS bind RseA.
Thus, even if binding were saturated in the cell, the vast majority
of RseA would bind inactive DegS, leaving the system poised for
activation. Indeed, genetic experiments suggest that RseA
binding to inactive DegS may prevent cleavage by downstream
proteases in the sE-activation cascade until robust OMP-depen-
dent activation occurs (Grigorova et al., 2004).
A Pathway for Peptide-Stabilized Changes
in DegS Conformation
In active DegS, the side chain of Met319 packs against the
aromatic ring of the C-terminal phenylalanine in the OMPpeptide
(Figure 1B; Wilken et al., 2004). In inactive DegS, this methionine
assumes a different rotamer that would clash with the peptide in
the ‘‘active’’ conformation. When we changed Met319 to Ala, the
affinity of OMP peptides for the inactive conformation of DegS
increasedmore than 10-fold, indicating that theMet319 side chain
normally hinders OMP peptide binding to this conformation.
We propose that peptide-induced changes in the Met319 side-
chain conformation are part of the mechanism by which peptide
binding stabilizes active DegS. The adjacent residue, Asp320,
makes a salt bridge with Arg178 in inactive DegS, stabilizing
this conformation relative to active DegS (Figure 1B; Wilken
et al., 2004; Zeth, 2004; Sohn et al., 2007). OMP peptide binding
to inactive DegS should force movement of the Met319 side
chain, and our mutant results indicate that the resulting confor-
mation is strained. This initial binding strain, in turn, should favor
conformational changes that break the Asp320dddArg178 salt
bridge, allowing Arg178 to move. In active DegS, Arg178 is known
to make a new set of interactions with the protease domain that
help to stabilize the active oxyanion-hole conformation (Fig-
ure 1B; Wilken et al., 2004; Sohn et al., 2007). Hence, unfavor-
able contacts between the Met319 side chain and OMP peptidein inactive DegS seem to be an important part of the network
of interactions that determine the relative stabilities of the
peptide-bound tense and relaxed conformations of DegS. We
note, however, that the M319A mutant is still activated, albeit
poorly, by OMP peptide binding. Thus, additional peptide-medi-
ated interactions must also contribute to altering the energy
balance between allosteric conformations.
Allosteric Models
The concerted MWC model of allostery provides a basis for
understanding regulation of DegS protease activity by OMP
peptide and substrate binding. Moreover, this model, in combi-
nation with the equilibrium and kinetic parameters listed in Table
1, provides a good quantitative fit of a wide range of experi-
mental data. We anticipate that this information will help in
modeling of the envelope-stress response in the cell. Our results
do not rule out more complicated allosteric models, including
sequential models in which hybridmixtures of T state and R state
subunits are allowed in a single DegS trimer (Koshland et al.,
1966) or models in which more than two allosteric conformations
of the enzyme are allowed. Indeed, crystallographic studies
reveal a structural intermediate between the peptide-bound
and peptide-free conformations of DegS (Wilken et al., 2004).
However, different structures that are nearly isoenergetic will
approximate a single functional state of the system. Hence, we
believe that the relative simplicity of the MWC model is well
suited for describing allosteric regulation of DegS.
Regulatory Implications for Related PDZ Proteases
DegS is part of an enzyme family with siblings in organisms
ranging from bacteria to humans (Kim and Kim, 2005). These
enzymes, which can serve as stress-sensing proteases and/or
as molecular chaperones, affect myriad processes including
microbial virulence and apoptotic regulation in mammalian cells.
It seems likely that the activities of many of these proteases will
be controlled in ways similar to DegS, specifically by peptide
binding to both active and inactive enzyme conformations.
Indeed, the results presented here suggest that it should be
possible to select or design peptides ormimics that act as potent
activators or inhibitors of these enzymes. It will also be inter-
esting to determine if any of these systems are subject to nega-
tive biological regulation by peptide signals that bind preferen-
tially to the inactive enzyme.
EXPERIMENTAL PROCEDURES
Proteins and Peptides
E. coli DegS (residues 27–355) lacking the wild-type membrane anchor and
containing an N-terminal His6 tag, a related His6-tagged DegS variant without
the PDZ domain (residues 27–256), and a 35S-labeled variant of the periplas-
mic domain of E. coli RseA (residues 121–216) with a C-terminal His6 tag
were expressed and purified as described (Walsh et al., 2003; Cezairliyan
and Sauer, 2007; Sohn et al., 2007). Mutations were generated by the Quik-
Change method (Stratagene) and confirmed by DNA sequencing. Mutant
proteins were expressed and purified by the same methods used for the
wild-type counterparts. Wild-type and mutant DegS proteins eluted as trimers
in the gel-filtration step of purification. Proteins were stored in 50 mMNaHPO4
(pH 8.0), 200 mMNaCl, 10% glycerol, and 2 mM EDTA. Peptides were synthe-
sized by the MIT Biopolymer Laboratory and purified by HPLC, and the ex-
pected molecular mass was confirmed by MALDI-TOF mass spectrometry.Molecular Cell 33, 64–74, January 16, 2009 ª2009 Elsevier Inc. 73
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by addition of an N-terminal fluoresceine during synthesis.
Enzymatic and Biochemical Assays
Unless noted, assays were performed at room temperature (23 ± 1C) in
150 mM NaHPO4 (pH 8.3), 380 mM NaCl, 10% glycerol, and 4 mM EDTA.
DegS cleavage of 35S-labeled periplasmic domain of RseA was quantified
by scintillation counting after separation of the N-terminal cleavage fragment
from uncleaved substrate and the C-terminal fragment by differential acid
solubility (Sohn et al., 2007). The binding of DegS or mutant variants to a fluo-
rescent OMP peptide was assayed by changes in fluorescence anisotropy
(excitation 480 nm; emission 520 nm), after correction for protein scattering.
Binding curves, Michealis-Menten curves, and peptide-activation curves
were fitted to appropriate equations using the nonlinear least squares subrou-
tine in KaleidaGraph (Synergy software).
Rhodamine-FP (Liu et al., 1999) was a gift from C. Salisbury, E. Weerapana,
andB.Cravatt (Scripps Institute).ModificationofDegSorvariants (0.9mMtrimer)
withRhodamine-FP (20mM)wasperformed in thepresenceor absenceofOMP-
like peptides. After quenching reactions by addition of an equal volume of 33
Laemmli sample buffer and boiling, samples were analyzed by SDS-PAGE
and fluorescence was quantified using an Amersham Typhoon imager (excita-
tion 532 nm; emission 588 nm). Initial rates were determined from the linear
phase of the reaction (generally 0–2 min). Rhodamine-FP modification was not
observed for aDegSvariant inwhich theactive-site serinewasmutated (S201A).
Fitting and Modeling
Steady-state kinetic parameters were obtained by fitting data to the Hill form of
the Michaelis-Menten equation using the nonlinear least squares subroutine in
the program KaleidaGraph (Synergy software). Equations from the MWC
model of allostery were also used to fit experimental data using subroutines
in ORIGIN (global fit; OriginLab) and MATLAB (lsqnonlin; MathWorks),
assuming that R state but not T state subunits are enzymatically active. The
substrate dependence of DegS cleavage of RseA was fit to the equation
rate= ½DegS3 krað1+aÞ
2
ð1+aÞ3 + L0ð1+ csaÞ3
; (1)
where kr is the rate constant for RseA cleavage, a is [substrate]/KRS, cs is KRS/
KTS, and L0 is T0/R0. To fit data obtained in the presence of saturating OMP-like
peptides, Equation 1 was modified by substituting LPapp (L0dcp
3) for L0, where
cp is KRP/KTP. The peptide dependence of DegS cleavage of RseA was fit to
the equation
rate=
Amaxbð1+ bÞ2
ð1+ bÞ3 + LSappð1+ cpbÞ3
+A0; (2)
where A0 is basal peptide-independent activity, Amax is kr[DegS3]a/(1-a)-A0,
b is [peptide]/KRP, and LSapp is L0(1+csa)
3/(1+a)3.
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